Global PD-L1 Biomarker Testing Competitive Landscape Professional Research Report 2024

Research Summary

PD-L1 (Programmed Cell Death Ligand 1) biomarker testing is a diagnostic procedure used in oncology to determine the level of PD-L1 protein expression on the surface of cancer cells. It plays a crucial role in the field of cancer immunotherapy, particularly in the treatment of solid tumors with immune checkpoint inhibitors. The test involves analyzing tissue samples from a patient's tumor to assess the presence and degree of PD-L1 expression. The results of PD-L1 biomarker testing help oncologists and clinicians predict the patient's potential response to immunotherapies that target the PD-1/PD-L1 pathway. Higher PD-L1 expression is often associated with a better response to these treatments, making it a valuable tool in personalized cancer care by guiding treatment decisions and improving the effectiveness of immunotherapy for patients with certain types of cancer.

According to DIResearch's in-depth investigation and research, the global PD-L1 Biomarker Testing market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of PD-L1 Biomarker Testing include Agilent Technologies, Roche, Merck, Bristol-Myers Squibb, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of PD-L1 Biomarker Testing. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global PD-L1 Biomarker Testing market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the PD-L1 Biomarker Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of PD-L1 Biomarker Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of PD-L1 Biomarker Testing Include:

Agilent Technologies

Roche

Merck

Bristol-Myers Squibb

AstraZeneca

Ono Pharmaceutical

Regeneron

Innovent

Hengrui Medicine

Junshi Biosciences

PD-L1 Biomarker Testing Product Segment Include:

PD-L1 (22C3)

PD-L1(28-8)

PD-L1 (SP142)

PD-L1 (SP263)

Others

PD-L1 Biomarker Testing Product Application Include:

Hospital

Diagnostic Center

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global PD-L1 Biomarker Testing Industry PESTEL Analysis

Chapter 3: Global PD-L1 Biomarker Testing Industry Porter's Five Forces Analysis

Chapter 4: Global PD-L1 Biomarker Testing Major Regional Market Size and Forecast Analysis

Chapter 5: Global PD-L1 Biomarker Testing Market Size and Forecast by Type and Application Analysis

Chapter 6: North America PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa PD-L1 Biomarker Testing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global PD-L1 Biomarker Testing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 PD-L1 Biomarker Testing Market Overview

1.1 Product Definition and Statistical Scope

1.2 PD-L1 Biomarker Testing Product by Type

1.2.1 Global PD-L1 Biomarker Testing Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 PD-L1 (22C3)

1.2.3 PD-L1(28-8)

1.2.4 PD-L1 (SP142)

1.2.5 PD-L1 (SP263)

1.2.6 Others

1.3 PD-L1 Biomarker Testing Product by Application

1.3.1 Global PD-L1 Biomarker Testing Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Others

1.4 Global PD-L1 Biomarker Testing Market Revenue Analysis (2019-2030)

1.5 PD-L1 Biomarker Testing Market Development Status and Trends

1.5.1 PD-L1 Biomarker Testing Industry Development Status Analysis

1.5.2 PD-L1 Biomarker Testing Industry Development Trends Analysis

2 PD-L1 Biomarker Testing Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 PD-L1 Biomarker Testing Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global PD-L1 Biomarker Testing Market Analysis by Regions

4.1 PD-L1 Biomarker Testing Overall Market: 2023 VS 2024 VS 2030

4.2 Global PD-L1 Biomarker Testing Revenue and Forecast Analysis (2019-2030)

4.2.1 Global PD-L1 Biomarker Testing Revenue and Market Share by Region (2019-2024)

4.2.2 Global PD-L1 Biomarker Testing Revenue Forecast by Region (2025-2030)

5 Global PD-L1 Biomarker Testing Market Size by Type and Application

5.1 Global PD-L1 Biomarker Testing Market Size by Type

5.2 Global PD-L1 Biomarker Testing Market Size by Application

6 North America

6.1 North America PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America PD-L1 Biomarker Testing Market Size by Type

6.4 North America PD-L1 Biomarker Testing Market Size by Application

6.5 North America PD-L1 Biomarker Testing Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe PD-L1 Biomarker Testing Market Size by Type

7.4 Europe PD-L1 Biomarker Testing Market Size by Application

7.5 Europe PD-L1 Biomarker Testing Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China PD-L1 Biomarker Testing Market Size by Type

8.4 China PD-L1 Biomarker Testing Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) PD-L1 Biomarker Testing Market Size by Type

9.4 APAC (excl. China) PD-L1 Biomarker Testing Market Size by Application

9.5 APAC (excl. China) PD-L1 Biomarker Testing Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America PD-L1 Biomarker Testing Market Size by Type

10.4 Latin America PD-L1 Biomarker Testing Market Size by Application

10.5 Latin America PD-L1 Biomarker Testing Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa PD-L1 Biomarker Testing Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type

11.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application

11.5 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global PD-L1 Biomarker Testing Market Revenue by Key Manufacturers (2020-2024)

12.2 PD-L1 Biomarker Testing Competitive Landscape Analysis and Market Dynamic

12.2.1 PD-L1 Biomarker Testing Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Agilent Technologies

13.1.1 Agilent Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Portfolio

13.1.3 Agilent Technologies PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Roche

13.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Roche PD-L1 Biomarker Testing Product Portfolio

13.2.3 Roche PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Merck

13.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Merck PD-L1 Biomarker Testing Product Portfolio

13.3.3 Merck PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Bristol-Myers Squibb

13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Bristol-Myers Squibb PD-L1 Biomarker Testing Product Portfolio

13.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 AstraZeneca

13.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 AstraZeneca PD-L1 Biomarker Testing Product Portfolio

13.5.3 AstraZeneca PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Ono Pharmaceutical

13.6.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Ono Pharmaceutical PD-L1 Biomarker Testing Product Portfolio

13.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Regeneron

13.7.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Regeneron PD-L1 Biomarker Testing Product Portfolio

13.7.3 Regeneron PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Innovent

13.8.1 Innovent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Innovent PD-L1 Biomarker Testing Product Portfolio

13.8.3 Innovent PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Hengrui Medicine

13.9.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Hengrui Medicine PD-L1 Biomarker Testing Product Portfolio

13.9.3 Hengrui Medicine PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Junshi Biosciences

13.10.1 Junshi Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Junshi Biosciences PD-L1 Biomarker Testing Product Portfolio

13.10.3 Junshi Biosciences PD-L1 Biomarker Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 PD-L1 Biomarker Testing Industry Chain Analysis

14.2 PD-L1 Biomarker Testing Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 PD-L1 Biomarker Testing Typical Downstream Customers

14.4 PD-L1 Biomarker Testing Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Polystyrene-Plastic Material And Resins Market (2024 Edition): Analysis By End-User Industry (Packaging Industry, Construction, Consumer, Electronics, and Other End-User Industries), By Product Type, By Application, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Ultra High Molecular Weight Polyethylene (UHMWPE) Fiber Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Form (Tapes, Sheets and Films, Fibers, Rods & Tubes and Other Forms), Processing Method, Grade, Region, By Country: 2020-2030

Global Food & Beverage Non-woven Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Polyethylene, Rayon and Other Materials), Product Type, End-Use, Region, By Country: 2020-2030

Global Transportation Protective Films Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material Type (PP Films, PE Films, PVC Films, PET Films and Other Material Types), End-Use Industry, Class Type, Region, By Country: 2020-2030

Global Short Fiber Thermoplastic Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Resin Type (Polypropylene, Polyamide, PEEK, PBT and Other Resin Types), Application, Reinforcement Type, Region, By Country: 2020-2030

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support